Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease

Iron deficiency, anemia, hyperphosphatemia, and increased fibroblast growth factor 23 (FGF23) are common and interrelated complications of chronic kidney disease (CKD) that are linked to CKD progression, cardiovascular disease and death. Ferric citrate is an oral phosphate binder that decreases diet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Kidney Int
Main Authors: Francis, Connor, Courbon, Guillaume, Gerber, Claire, Neuburg, Samantha, Wang, Xueyan, Dussold, Corey, Capella, Maralee, Qi, Lixin, Isakova, Tamara, Mehta, Rupal, Martin, Aline, Wolf, Myles, David, Valentin
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875640/
https://ncbi.nlm.nih.gov/pubmed/31668632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.07.026
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares